By Tony Fong

NEW YORK (GenomeWeb News) – A slowly improving economy and increasing interest in the potential payoff from molecular diagnostics bodes well for mergers and acquisitions, particularly in the MDx space, according to some experts.

Last year's economic recession resulted in one of the weakest M&A environments in recent memory, but the first half of 2010 has seen a gradual recovery that some say will continue through the balance of the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.